I critique Baxter International's capital allocation decisions, stating the stock is not suitable for popular investment strategies. See why I rate BAX a sell.

We also respect individual opinions––they represent the unvarnished thinking of our people and exacting analysis of our research processes. Our authors can publish views that we may or may not ...

Baxter International’s longtime CEO and board chair José Almeida is stepping down and retiring, effective immediately, the ...

If you’re on the fence about investing in Smith & Nephew plc or Baxter International Inc. because you’re not sure how they measure up, it’s important to compare them on a few factors before making ...

Vantive builds on a 70-year legacy of kidney care leadership and innovation, with a singular focus on empowering patients and ...